Losartan Potassium prices in the Chinese market were back on the rise in the first half of October 2025 after a 0.6% slump in September. The upswing was due to renewed demand and some importers restocking, after a tough September that saw prices drop due to the government slashing API prices, the yuan appreciating and lingering oversupply following production getting back up and running. Despite the steady demand for hypertension meds, a cautious approach to buying and stock levels in check kept market activity subdued. But in early October, buyers started getting back into the market and restocking as they looked to get their stock levels back in sync with production cycles. Zhejiang did a better job of coordinating exports and supply was looking stable which just helped the recovery. Market experts reckon that prices will start going up a bit in the second half of October as the restocking continues. So long as demand stays strong, production stays steady and people keep buying, the market should stay firm throughout the month, which is good news for the Chinese pharmaceutical API sector.
Losartan Potassium prices in the Chinese market bounced back in the first half of October 2025, after a slight dip in September. Demand for Losartan Potassium is picking up again, and importers are trying to replenish their stock after a brief downturn in orders. The mild dip in September was due to a push from the government to lower prices on key APIs, lingering supply issues from production ramping back up, and the Chinese yuan getting a bit stronger against the US dollar. All of this led to softer export prices and more cautious buying from international customers and domestically.
In September 2025, the Losartan Potassium market took a bit of a hit, when the government decided to cut prices on generic drugs to make them more affordable and keep the industry competitive and on par with the rest of the world. Despite steady, ongoing demand for Losartan Potassium as a treatment for hypertension, the overall oversupply in the market combined with global buyers taking a more cautious approach to purchases kept prices pretty steady all things considered. Inventory levels at Zhejiang ports were well managed, this reduced the risk of any supply chain disruptions and helped keep a steady stream of Losartan Potassium flowing. And the exchange rate between the US dollar and the Chinese yuan ( hovering around 7.1 on average) also came into play & had an effect on price adjustments, essentially keeping the market in a state of moderate easing.
But things picked up in October as international buyers started to stock up again and reorder to keep up with production schedules. A significant increase in procurement activities and a growing demand for Losartan Potassium from importers keep the prices up. This led to manufacturers adjusting their production and supply chains to meet the new orders and the growing demand. Increased import activity, steady domestic consumption, and efficient logistics, those all contributed to a positive market environment for Losartan Potassium.
Those in the market noted that this uptick in October was not just about buying up inventory but a reflection of longer-term demand for Losartan Potassium, particularly in hypertension treatments. Exporters said that they had smoother coordination coming out of Zhejiang ports while domestic distributors were able to manage their existing Losartan Potassium stock well. This all helped to get prices back on track for Losartan Potassium and offset the dip in September.
Analysts reckon that while the September drop did give the market a bit of a scare, the bounce back in October shows how resilient the Losartan Potassium supply chain is. Having things in balance, steady demand, and restocking, all these helped bring things up to normal level and support a positive outlook for the rest of the month. And manufacturers are saying they are going to keep an eye on aligning with importers' buying cycles and keeping an eye on their inventory to keep the market stable.
Looking ahead, the experts think that Losartan Potassium prices in China will pick up again in the second half of October 2025. Losartan Potassium buyers expected to restock and get new production going, and with steady demand, the prices will go up. Analysts also think steady procurement and supply fundamentals will help keep the market in a good place. As international buyers get back on the strategic purchases, Losartan Potassium is likely to see a bit of a price bump, showing that the Chinese API market is resilient and adaptable.
